On February 12, 2010, Oxford Nutrascience Group PLC (ONG) completed the Placing of new ordinary shares raising £1.1 million and admitted its entire issued share capital to trading on AIM.
ONG is the holding company of Oxford Nutrascience Limited ("Oxford Nutrascience"), a UK consumer healthcare company that commercialises proprietary delivery systems for medicines and supplements using prebiotic technology. Oxford Nutrascience intends to continue its strategy of making self medication easier and more pleasant by increasing its product range and by the licensing of its intellectual property to major brand owners in the OTC and prescription pharmaceutical sectors.
Chris Chrysanthou, Daniel Joll, Stuart Richards, Antonina Cuffaro and Zehra Kasapoglu of Fasken Martineau advised Oxford Nutrascience Group PLC on this matter. Paul Yerbury and Rakesh Jhally advised on the tax aspects.